Shots: The focus of the P-III study is to demonstrate the comparability of FYB202 & the reference product Stelara in terms of efficacy, safety & immunogenicity in patients with moderate […]readmore
Tags : FYB202
The P-I study involves assessing of FYB202 vs Stelara in patients evaluating the PK, safety, and tolerability while their dosing has been started last week Bioeq GmbH to sponsor the […]readmore